GLAUKOS Corp (GKOS)

↓ Download CSV

CIK 0001192448 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, GLAUKOS Corp reported revenue of $507.44M, up 32.3% from the prior year. The company ran a net loss, with a net margin of -37.0% and a gross margin of 55.7%. It held $893.49M in total assets against $237.33M in total liabilities.

Key ratios (FY2025)

55.7%
Gross margin
-39.3%
Operating margin
-37.0%
Net margin
-28.6%
Return on equity
+32.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$507.44M$383.48M$314.71M$282.86M$294.01M$224.96M$236.98M$181.28M$159.25M$114.40M
Cost of Revenue$111.81M$94.03M$75.58M$68.98M$66.63M$91.72M$38.59M$25.07M$21.05M$16.18M
Gross Profit$282.76M$289.45M$239.14M$213.88M$227.38M$133.24M$198.40M$156.20M$138.20M$98.22M
Operating Income-$199.60M-$122.37M-$128.70M-$82.31M-$32.87M-$123.55M-$50.29M-$13.00M-$2.28M$4.24M
Net Income-$187.69M-$146.37M-$134.66M-$99.19M-$49.59M-$120.35M$15.42M-$12.95M-$92.0K$4.52M
EPS (Diluted)$-3.28$-2.77$-2.78$-2.09$-1.07$-2.70$0.37$-0.37$0.00$0.12
Total Assets$893.49M$974.76M$940.41M$1.00B$1.05B$1.01B$818.40M$206.97M$165.84M$134.37M
Total Liabilities$237.33M$207.82M$478.65M$472.38M$462.55M$338.05M$145.13M$33.11M$27.63M$17.10M
Shareholders' Equity$656.15M$766.93M$461.77M$530.00M$587.15M$667.45M$673.27M$173.86M$138.20M$117.27M
Cash & Equivalents$90.81M$169.63M$93.47M$119.53M$100.71M$96.60M$62.43M$29.82M$24.51M$6.49M
Operating Cash Flow-$14.79M-$61.32M-$57.76M-$33.08M$24.71M-$22.99M-$369.0K$18.86M$26.09M$12.31M
Capital Expenditures$7.67M$6.30M$20.25M$30.27M$47.78M$6.93M$4.72M$10.31M$6.31M$6.28M
Shares Outstanding57.51M56.44M49.12M47.75M46.97M45.25M43.50M36.11M34.62M33.94M